"Serum immunoregulatory proteins as predictors of overall survival of metastatic melanoma patients treated with ipilimumab." by Yoshinobu Koguchi

Selected Works of Walter J. Urba, MD, PhD

Article

Serum immunoregulatory proteins as predictors of overall survival of metastatic melanoma patients treated with ipilimumab.

Journal for ImmunoTherapy of Cancer (2015)

Yoshinobu Koguchi, Providence Portland Medical Center
Helena Hoen
Shelly Bambina, University of Pennsylvania
Michael Rynning
Richard Fuerstenberg
Zipei Feng, Oregon Health & Science University
Bernard Fox, Oregon Health & Science University
Carlo Bifulco, Providence Portland Medical Center
Brendan D Curti, Providence Portland Medical Center
Walter Urba
Christina Milburn, Bristol-Myers Squibb
Alan J Korman, Bristol-Myers Squibb
Keith S Bahjat, Providence Portland Medical Center

Link

Disciplines

Publication Date

January 1, 2015

DOI

10.1186/2051-1426-3-S2-P96

Citation Information

Yoshinobu Koguchi, Helena Hoen, Shelly Bambina, Michael Rynning, et al.. "Serum immunoregulatory proteins as predictors of overall survival of metastatic melanoma patients treated with ipilimumab." Journal for ImmunoTherapy of Cancer Vol. 3 Iss. 2 (2015) p. 96
Available at: http://works.bepress.com/walter-urba/126/